Biotech Ingredient Market Size, New Opportunities, Share, Growth, Key Segments And Forecast 2033

The biotech ingredient market size has grown strongly in recent years. It will grow from $56.76 billion in 2023 to $60.6 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to innovations in food and beverage industry, increasing adoption of biofuel, consumer demand for functional foods, advances in genetic engineering.

The biotech ingredient market size is expected to see strong growth in the next few years. It will grow to $78.43 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to focus on personalized nutrition, expansion of cell-based meat production, development of therapeutic biotech ingredients, bio ingredients for waste reduction, shift towards bioplastics. Major trends in the forecast period include biotech-based functional foods, biotech solutions for circular economy practices, therapeutic biotech ingredients, biotech ingredients for clean energy production, global emphasis on biodiversity conservation.

Market Overview -
Biotech ingredients refer to chemical components produced by microbes, most commonly yeast, yeast-like organisms, or algae that have their DNA edited such that their metabolism results in a commercially viable compound. These ingredients are safer and are often less expensive for consumers.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

The Surging Demand For Generic Medicines Boosting Growth In The Biotech Ingredient Market
The rising demand for generic medicines is expected to propel the growth of the biotech ingredient market going forward. A generic medicine refers to a drug that is designed to have the same properties as a previously approved medicine. Biotech ingredients are used in general medicine as they are the primary source for providing less costly, more efficient means of producing a range of active ingredients that are almost identical to the original product and are typically regulated under an extended set of rules. For instance, in September 2022, according to the U.S. Generic and Biosimilar Medicines Savings Report published by the Association for Accessible Medicines (AAM), a US-based association of generic medicine manufacturers and distributors, and the Biosimilars Council, a part of the AAM association, patients in the United States received 6.4 billion prescriptions in 2021, with an increase of 91% of them being generic or biosimilar medications. Patients, customers, employers, and taxpayers saved $373 billion by using these lower-cost medicines where generics medicines represent 3% of all health care spending. Therefore, the rising demand for generic medicines is driving the growth of the biotech ingredient market.

Competitive Landscape -
Major companies operating in the biotech ingredient market report are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc. .

Innovative Biotech Solutions Transforming The Cosmeceutical Landscape
Technological advancement has emerged as the key trend gaining popularity in the biotech ingredient market. Major companies operating in the biotech ingredient market are introducing new technologies to develop innovative products to strengthen their position in the market. For instance, in March 2023, International Flavors & Fragrances Inc., a US-based manufacturer of fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, launched Aurist AGC, a novel biopolymer for hair care. This illustrates the new DEB platform's potential by utilizing IFF's comprehensive biotechnology functionality to ensure sustained and high-performance glamour solutions that really can truly contribute to change in the cosmeceutical industry. The ingredient uses IFF's proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnology capable of producing novel biobased polysaccharides with distinct structures and product features.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Key Segments -
The biotech ingredient market covered in this report is segmented -
1) By Type: Active Pharmaceutical Ingredients, Biosimilars
2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems
3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.